A considerably greater risk of NSCLC was linked to the T/T genotype of the IL-1β-31 gene, as reported by Bhat et al. (P = 0.001; odds ratio [OR], 2.8; 95% confidence interval [CI], 1.52–5.26). This evidence concerns the gene IL1B and non-small cell lung carcinoma.